하이로닉 인터내셔널 웹사이트로 이동합니다.
인터내셔널 웹사이트에는 수출용 제품으로 대한민국에서 허가하지 않은 장비 및 서비스 내용을 포함하고 있습니다. 해당 내용은 대한민국의 의료기기 광고 심의, 규제를 받지 않습니다.
It goes to the HIRONIC INTL. website.
The Intrrnation Web Site contains equipment and services that are not authorized by the Republic of Korea These contents are not subject to review and regulation of medical devices in Korea.
하이로닉 US 웹사이트로 이동합니다.
US 웹사이트의 내용은 "FDA"로 부터 허가승인된 품목의 제품 정보에 관한 것으로, 대한민국의 소비자 보호를 위한 국내법 의료기기의 광고 심의, 규제를 받지 않습니다.
It goes to the HIRONIC US website.
The contents of the US web page are about product information of items approved for "FDA". They are not subject to advertising deliberation and regulation of domestic law medical devices for consumer protection in Korea.
하이로닉 EU 웹사이트로 이동합니다.
EU 웹사이트의 내용은 "CE MDD 또는 CE MDR"로 부터 허가승인된 품목의 제품 정보에 관한 것으로, 대한민국의 소비자 보호를 위한 국내법 의료기기의 광고 심의, 규제를 받지 않습니다.
It goes to the HIRONIC EU website.
The contents of the EU(European) web page are about product information of items approved for "CEMDD or CEMDR" in EU countries. They are not subject to advertising deliberation and regulation of domestic law medical devices for consumer protection in Korea.
HIRONIC Co., Ltd a leading company in energy-based medical aesthetic devices, showcased its new product SYNERJET PRO™ at Dubai Derma 2025, the largest medical aesthetics exhibition in the Middle East.
At the event, HIRONIC introduced SYNERJET PRO™, a needle-free drug delivery device, as its flagship product. The system combines Micro-Jetting, Electroporation, and Plasma technologies to deliver active ingredients uniformly into the dermal layer.
Designed to minimize the discomfort and psychological burden associated with traditional needle injections, SYNERJET PRO™ drew attention for its potential application in various areas such as skin boosters and anti-aging treatments. During the exhibition, the product received positive feedback from local medical professionals, who noted its strong alignment with the growing demand in the Middle Eastern medical aesthetics market.
Prior to Dubai Derma, HIRONIC had already introduced SYNERJET PRO™ at several major international exhibitions, including IMCAS Paris 2025 in January and AAD and KIMES 2025 in March.
“The SYNERJET PRO™ is one of HIRONIC’s next-generation global strategy products, developed to overcome the technical limitations of previous needle-free injectors,” said a HIRONIC representative in charge of the Middle East region. “The enthusiastic response at Dubai Derma has reinforced our confidence in both the product strategy and brand direction.”
HIRONIC is also scheduled to participate in IMCAS Asia 2025, to be held this June in Bangkok, where the company will conduct live demonstrations and academic sessions centered on SYNERJET PRO™.
